Engineered Dendritic Cell Vaccine Draws Immune Cells Into Lung Tumors but Falls Short of Shrinkage
A phase I trial found that a CCL21-engineered dendritic cell vaccine combined with pembrolizumab safely increased T cell infiltration in ...
A phase I trial found that a CCL21-engineered dendritic cell vaccine combined with pembrolizumab safely increased T cell infiltration in ...
An exploratory study of 61 breast cancer patients found only weak, statistically fragile links between regional tumor immune-stromal composition and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine